Fig. 1.
CH11 effect on cell viability.
Cells (4 × 105/mL) were treated by CH11 (2 μg/mL for KG1a and U937; 0.5 μg/mL for Jurkat) or IgM isotypic control for different time periods. Cell viability was evaluated by Trypan blue exclusion assay. (A) KG1a cells treated by CH11 (▪) or IgM (■). (B) Jurkat cells treated by CH11 (●) or IgM (○), U937 cells treated by CH11 (▴) or IgM (▵). Results are the mean ± standard deviation of 3 independent experiments.
